Search

7 September 2023 - The Stem Cell Therapies Mission Expert Advisory Panel (EAP) advised the government on the research priorities for this mission, which is funded by the Medical Research Future Fund (MRFF).

18 December 2021 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 15 December 2021.

11 October 2024 - This video highlights the importance of cervical screening and supporting women to take control of their own health.

11 June 2025 - Summary of the consideration of the application from Alexion Australia for the inclusion of sebelipase alfa (Kanuma®) on the LSDP for the treatment of infantile onset lysosomal acid lipase deficiency (LAL-D).

11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access certain medications for Gaucher disease (type 1) under the Life Saving Drugs Program.

11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type VI (MPS VI) under the Life Saving Drugs Program.

11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type I (MPS I) under the Life Saving Drugs Program.

11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type II (MPS II) under the Life Saving Drugs Program.

11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type IVA (MPS IVA) under the Life Saving Drugs Program.

1 September 2025 - Information on vaccines you need to keep you and your family safe from diseases.